FDA needs to loosen up on CBD but clamp down on quality claims By: MarketWatch May 22, 2019 at 08:33 AM EDT Enhance consumer protections by establishing product quality-assurance standards, not by restricting access to CBD. Read More >> Related Stocks: CVS Health Corp Walgreens Boots Alliance